Koichi Saruwatari
Kumamoto University
35 Papers
28 Citations
Koichi Saruwatari is an academic researcher from Kumamoto University. The author has contributed to research in topics: Lung cancer & Medicine. The author has an hindex of 8, co-authored 24 publications.
Chat about Author
Papers
Signaling through the Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Axis Is Responsible for Aerobic Glycolysis mediated by Glucose Transporter in Epidermal Growth Factor Receptor (EGFR)-mutated Lung Adenocarcinoma.
Hideki Makinoshima,Masahiro Takita,Koichi Saruwatari,Shigeki Umemura,Yuuki Obata,Genichiro Ishii,Shingo Matsumoto,Eri Sugiyama,Atsushi Ochiai,Ryo Abe,Koichi Goto,Hiroyasu Esumi,Katsuya Tsuchihara +12 more
TL;DR: The results suggest that PI3K/AKT/mTOR signaling is indispensable for the regulation of aerobic glycolysis in EGFR-mutant lung adenocarcinoma (LAD) cell lines with activating EGFR mutations.
178
Association of Probiotic Clostridium butyricum Therapy with Survival and Response to Immune Checkpoint Blockade in Patients with Lung Cancer.
Yusuke Tomita,Tokunori Ikeda,Shinya Sakata,Koichi Saruwatari,Ryo Sato,Shinji Iyama,Takayuki Jodai,Kimitaka Akaike,Shiho Ishizuka,Sho Saeki,Takuro Sakagami +10 more
TL;DR: Probiotic CBT may have a positive impact on therapeutic efficacy of ICB in patients with cancer, and is associated with longer PFS and OS even in patients who received antibiotic therapy.
Disorder of Coagulation-Fibrinolysis System: An Emerging Toxicity of Anti-PD-1/PD-L1 Monoclonal Antibodies
Ryo Sato,Kosuke Imamura,Shinya Sakata,Tokunori Ikeda,Yuko Horio,Shinji Iyama,Kimitaka Akaike,Shohei Hamada,Takayuki Jodai,Kei Nakashima,Shiho Ishizuka,Nahoko Sato,Koichi Saruwatari,Sho Saeki,Yusuke Tomita,Takuro Sakagami +15 more
TL;DR: A previously unrecognized pivotal role for immune activation in triggering disorders of the coagulation-fibrinolysis system in cancer patients during treatment with ICI is suggested.
68
Acute coronary syndrome as a possible immune-related adverse event in a lung cancer patient achieving a complete response to anti-PD-1 immune checkpoint antibody.
Yusuke Tomita,Daisuke Sueta,Yosuke Kakiuchi,Sho Saeki,Koichi Saruwatari,Shinya Sakata,Takayuki Jodai,Yohei Migiyama,Kimitaka Akaike,Susumu Hirosako,Koichiro Fujisue,Satoru Yamamura,S. Miyazaki,Seiji Takashio,Yasuhiro Izumiya,K. Nakamura,Kenichi Tsujita,Hidenori Ichiyasu,K. Fujii +18 more
57
Disorder of Coagulation-Fibrinolysis System: An Emerging Toxicity of Anti-PD-1/PD-L1 Monoclonal Antibodies
Kosuke Imamura,Ryo Sato,Shinya Sakata,Tokunori Ikeda,Yuko Horio,Shinji Iyama,Kimitaka Akaike,Shohei Hamada,Takayuki Jodai,Kei Nakashima,Shiho Ishizuka,Nahoko Sato,Koichi Saruwatari,Sho Saeki,Yusuke Tomita,Hidenori Ichiyasu,Takuro Sakagami +16 more
- 01 May 2020
40